| Heterodimerization of dopamine receptors: new insights into functional and therapeutic significance R Maggio, G Aloisi, E Silvano, M Rossi, MJ Millan Parkinsonism & related disorders 15, S2-S7, 2009 | 88 | 2009 |
| β-arrestin-2 is an essential regulator of pancreatic β-cell function under physiological and pathophysiological conditions L Zhu, J Almaça, PK Dadi, H Hong, W Sakamoto, M Rossi, RJ Lee, ... Nature communications 8 (1), 14295, 2017 | 86 | 2017 |
| Muscarinic receptors as model targets and antitargets for structure-based ligand discovery AC Kruse, DR Weiss, M Rossi, J Hu, K Hu, K Eitel, P Gmeiner, J Wess, ... Molecular pharmacology 84 (4), 528-540, 2013 | 78 | 2013 |
| The tetrahydroisoquinoline derivative SB269, 652 is an allosteric antagonist at dopamine D3 and D2 receptors E Silvano, MJ Millan, CM la Cour, Y Han, L Duan, SA Griffin, RR Luedtke, ... Molecular pharmacology 78 (5), 925-934, 2010 | 66 | 2010 |
| Hepatic β-arrestin 2 is essential for maintaining euglycemia L Zhu, M Rossi, Y Cui, RJ Lee, W Sakamoto, NA Perry, NM Urs, ... The Journal of clinical investigation 127 (8), 2941-2945, 2017 | 44 | 2017 |
| The thyroid disruptor 1, 1, 1-trichloro-2, 2-bis (p-chlorophenyl)-ethane appears to be an uncompetitive inverse agonist for the thyrotropin receptor M Rossi, A Dimida, MT Dell'anno, ML Trincavelli, P Agretti, F Giorgi, ... Journal of Pharmacology and Experimental Therapeutics 320 (1), 465-474, 2007 | 44 | 2007 |
| The first negative allosteric modulator for dopamine D2 and D3 receptors, SB269652 may lead to a new generation of antipsychotic drugs M Rossi, I Fasciani, F Marampon, R Maggio, M Scarselli Molecular pharmacology 91 (6), 586-594, 2017 | 43 | 2017 |
| Central IGF1 improves glucose tolerance and insulin sensitivity in mice H Hong, ZZ Cui, L Zhu, SP Fu, M Rossi, YH Cui, BM Zhu Nutrition & Diabetes 7 (12), 2, 2017 | 41 | 2017 |
| Regulation of M3 muscarinic receptor expression and function by transmembrane protein 147 E Rosemond, M Rossi, SM McMillin, M Scarselli, JG Donaldson, J Wess Molecular pharmacology 79 (2), 251-261, 2011 | 40 | 2011 |
| Dopamine D2 receptors dimers: how can we pharmacologically target them? M Carli, S Kolachalam, S Aringhieri, M Rossi, L Giovannini, R Maggio, ... Current neuropharmacology 16 (2), 222-230, 2018 | 39 | 2018 |
| AG Protein-biased Designer G Protein-coupled Receptor Useful for Studying the Physiological Relevance of Gq/11-dependent Signaling Pathways*♦ J Hu, M Stern, LE Gimenez, L Wanka, L Zhu, M Rossi, J Meister, A Inoue, ... Journal of Biological Chemistry 291 (15), 7809-7820, 2016 | 36 | 2016 |
| Hepatic Gi signaling regulates whole-body glucose homeostasis M Rossi, L Zhu, SM McMillin, SP Pydi, S Jain, L Wang, Y Cui, RJ Lee, ... The Journal of clinical investigation 128 (2), 746-759, 2018 | 35 | 2018 |
| Gs-DREADD knock-in mice for tissue-specific, temporal stimulation of cyclic AMP signaling D Akhmedov, MG Mendoza-Rodriguez, K Rajendran, M Rossi, J Wess, ... Molecular and cellular biology 37 (9), e00584-16, 2017 | 33 | 2017 |
| CK2 acts as a potent negative regulator of receptor-mediated insulin release in vitro and in vivo M Rossi, I Ruiz de Azua, LF Barella, W Sakamoto, L Zhu, Y Cui, H Lu, ... Proceedings of the National Academy of Sciences 112 (49), E6818-E6824, 2015 | 30 | 2015 |
| Minireview: Novel Aspects of M3 Muscarinic Receptor Signaling in Pancreatic β-Cells K Nakajima, S Jain, I Ruiz de Azua, SM McMillin, M Rossi, J Wess Molecular endocrinology 27 (8), 1208-1216, 2013 | 30 | 2013 |
| Presence of a putative steroidal allosteric site on glycoprotein hormone receptors M Rossi, A Dimida, E Ferrarini, E Silvano, G De Marco, P Agretti, G Aloisi, ... European journal of pharmacology 623 (1-3), 155-159, 2009 | 24 | 2009 |
| Fluorescent light induces neurodegeneration in the rodent nigrostriatal system but near infrared LED light does not S Romeo, F Vitale, C Viaggi, S di Marco, G Aloisi, I Fasciani, C Pardini, ... Brain research 1662, 87-101, 2017 | 23 | 2017 |
| The cell biology of the thyroid-disrupting mechanism of dichlorodiphenyltrichloroethane (DDT) M Rossi, AR Taddei, I Fasciani, R Maggio, F Giorgi Journal of Endocrinological Investigation 41, 67-73, 2018 | 22 | 2018 |
| Spinophilin as a novel regulator of M3 muscarinic receptor-mediated insulin release in vitro and in vivo IR de Azua, K Nakajima, M Rossi, Y Cui, W Jou, O Gavrilova, J Wess The FASEB Journal 26 (10), 4275, 2012 | 22 | 2012 |
| Thyroid disruptor 1, 1, 1-trichloro-2, 2-bis (p-chlorophenyl) ethane (DDT) prevents internalization of TSH receptor S Picchietti, M Belardinelli, AR Taddei, AM Fausto, M Pellegrino, ... Cell and tissue research 336, 31-40, 2009 | 22 | 2009 |
